Researchclopedia

Research Researchers Institutions Topics Submit About

Command Palette

Search for a command to run...

Researchclopedia

Research Researchers Institutions About

© 2026 Researchclopedia. Powered by OpenAlex under CC0 license.

Dragonfly Therapeutics (United States) | Researchclopedia

Back to institutions

Dragonfly Therapeutics (United States)

Walthamcompany

22

Works

529

Citations

16

h-index

Top Research Topics

CAR-T cell therapy research Immune Cell Function and Interaction Monoclonal and Polyclonal Antibodies Research

Top Researchers

Michael A. Davies The University of Texas MD Anderson Cancer Center

1,440 works51,434 citationsh-index: 99

Recent Research

Fc-enhanced anti-CCR6 antibody elicits robust therapeutic effects across multiple autoimmune diseases

Jahangir Alam,Yu-Anne Yap,et al.

20260 citations

Cancer Immunotherapy and Biomarkers

Protein purification and stability

T-cell and B-cell Immunology

Acute Myeloid Leukemia Research

Cell Adhesion Molecules Research

3D Printing in Biomedical Research

Viral Infectious Diseases and Gene Expression in Insects

COVID-19 Clinical Research Studies

Nanoparticle-Based Drug Delivery

Hussein A. Tawbi The University of Texas MD Anderson Cancer Center

513 works24,496 citationsh-index: 61

Rodabe N. Amaria The University of Texas MD Anderson Cancer Center

319 works16,787 citationsh-index: 45

Jennifer L. McQuade The University of Texas MD Anderson Cancer Center

355 works11,619 citationsh-index: 48

61 works9,770 citationsh-index: 33

Nicolai Wagtmann TScan Therapeutics (United States)

59 works6,299 citationsh-index: 30

Abstract 3516: TriNKETs®: trispecific immune cell engager therapies exhibit potent preclinical in vivo anti-tumor activity and broad combinability in diverse cancer models

Colin LaCroix,Adam Stockmann,et al.

20251 citations

Agonistic anti-NKG2D antibody structure reveals unique stoichiometry and epitope compared to natural ligands

Daniel Fallon,Ching-Shin Huang,et al.

20242 citations

962 A novel alpha-active IL-2-Fc has expanded therapeutic index and robust monotherapy efficacy in mouse cancer models and strong synergy with PD-1 blockade

Adam Stockmann,S.R. Vincent,et al.

20240 citations

1060 DF9001, an EGFR targeted immune engager, stimulates innate and adaptive anti-tumor immunity with a distinctive safety profile

Mitchell Bigelow,Colin LaCroix,et al.

20242 citations

Subunit-Selective PI3K Inhibition to Reverse Immunotherapy Resistance: Phase I/II Study of PI3Kβ and Pembrolizumab in Advanced Solid Tumors with PTEN Loss

Hussein A. Tawbi,Elizabeth M. Burton,et al.

20240 citations